Manufacturer record
Bueno Salud Care India Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Bueno Salud Care India Pvt. Ltd (Gujarat) were declared Not of Standard Quality in March 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: 24PB001, Ceftriaxone Injection IP (Lorisol 1000) (exp Dec 2025). CDTL Mumbai (CDSCO lab) found it not of standard quality: Clarity of solution. Listed in the March 2024 alert.
Records by type
2 records linked to Bueno Salud Care India Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ceftriaxone Injection IP (Lorisol 1000) | Batch 24PB001Mfg Jan 2024 · Exp Dec 2025 | Clarity of solutionOther | CDTL MumbaiCDSCO lab | Mar 2024 |
| Amoxycillin Dispersible Tablets IP 500 mg (Edmax- 500 DT) | Batch 24TB004Mfg Jan 2024 · Exp Dec 2025 | Uniformity of weightUniformity of weight/content | CDTL MumbaiCDSCO lab | Mar 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.